Cargando…
Chemoprevention for the Populations of Malaria Endemic Africa
Drugs have been used to prevent malaria for centuries, but only recently have they been used on a large scale to prevent malaria in the resident population of malaria endemic areas in sub-Saharan Africa. This paper discusses some of the reasons for the hesitancy in adoption of chemopreventive strate...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680511/ https://www.ncbi.nlm.nih.gov/pubmed/36412595 http://dx.doi.org/10.3390/diseases10040101 |
_version_ | 1784834435837853696 |
---|---|
author | Greenwood, Brian Schellenberg, David |
author_facet | Greenwood, Brian Schellenberg, David |
author_sort | Greenwood, Brian |
collection | PubMed |
description | Drugs have been used to prevent malaria for centuries, but only recently have they been used on a large scale to prevent malaria in the resident population of malaria endemic areas in sub-Saharan Africa. This paper discusses some of the reasons for the hesitancy in adoption of chemopreventive strategies in sub-Saharan Africa, reasons why this hesitancy has been overcome in recent years and the range of target groups now identified by the World Health Organization as those who can benefit most from chemoprevention. Adoption of carefully targeted chemopreventive strategies could help reverse the recent stagnation in the decline in malaria in sub-Saharan Africa that had been taking place during the previous two decades. |
format | Online Article Text |
id | pubmed-9680511 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96805112022-11-23 Chemoprevention for the Populations of Malaria Endemic Africa Greenwood, Brian Schellenberg, David Diseases Commentary Drugs have been used to prevent malaria for centuries, but only recently have they been used on a large scale to prevent malaria in the resident population of malaria endemic areas in sub-Saharan Africa. This paper discusses some of the reasons for the hesitancy in adoption of chemopreventive strategies in sub-Saharan Africa, reasons why this hesitancy has been overcome in recent years and the range of target groups now identified by the World Health Organization as those who can benefit most from chemoprevention. Adoption of carefully targeted chemopreventive strategies could help reverse the recent stagnation in the decline in malaria in sub-Saharan Africa that had been taking place during the previous two decades. MDPI 2022-11-08 /pmc/articles/PMC9680511/ /pubmed/36412595 http://dx.doi.org/10.3390/diseases10040101 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Commentary Greenwood, Brian Schellenberg, David Chemoprevention for the Populations of Malaria Endemic Africa |
title | Chemoprevention for the Populations of Malaria Endemic Africa |
title_full | Chemoprevention for the Populations of Malaria Endemic Africa |
title_fullStr | Chemoprevention for the Populations of Malaria Endemic Africa |
title_full_unstemmed | Chemoprevention for the Populations of Malaria Endemic Africa |
title_short | Chemoprevention for the Populations of Malaria Endemic Africa |
title_sort | chemoprevention for the populations of malaria endemic africa |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680511/ https://www.ncbi.nlm.nih.gov/pubmed/36412595 http://dx.doi.org/10.3390/diseases10040101 |
work_keys_str_mv | AT greenwoodbrian chemopreventionforthepopulationsofmalariaendemicafrica AT schellenbergdavid chemopreventionforthepopulationsofmalariaendemicafrica |